Introduction:
Coronary artery disease remains the leading cause of death worldwide in spite of relentless effort and research and by the year 2020 it will hold first place in the World Health Organization's list of leading cause of disability. 1 It is one of the leading causes of death in the developed world as well as in the developing countries like Bangladesh. National data on incidence and mortality of coronary heart disease are few in Bangladesh. The incidence of coronary artery disease has increased from 3.3 per thousand to 14 per thousand from the year 1975 to 1985. 2 Major underlying mechanism of ischemic heart disease is atherosclerotic process in coronary arteries of heart. Atherosclerosis is a complex inflammatory-fibroproliferative response to deposition of plasma-derived atherogenic lipoprotein in the arterial intima (Falk & Fuster 2001) . 3 Acute coronary syndrome has commonly been shown to result from disruption of atherosclerotic plaque at a site of a high density of inflammatory cells. 4 Inflammation plays an important role in the initiation and progression of atherosclerosis by generating systemic blood markers of inflammation including C-reactive protein and proinflammatory cytokines, which in turn promote leukocyte, endothelial and smooth muscle cell activation, resulting in an increase in procoagulant activity, metalloproteinase release and neointimal proliferation. 5 So it has emerged as powerful predictors of coronary events. 6 Even small elevation of CRP within or just beyond the normal range, have been found to strongly predict future cardiovascular events in almost all studies. 7 Percutaneous coronary intervention (PCI) has continued expanding its role in the management of coronary atherosclerosis. Though much progress has been made with PCI, since its first inauguration by Andreas Gruntzig in 1977, its glory in many cases is thwarted by some adverse complications. To accurately stratify patients according to their risk of future adverse events, a quest for risk predictors is ongoing worldwide, but only a few powerful and independent predictors of early and late major adverse cardiovascular events have been found. These include traditional risk factors, such as acute coronary instability, diabetes mellitus, reference vessel diameter, and lesion and/or stent length. 8 Nonetheless, risk assessment is still incomplete if based only on such "traditional" prognostic variables. 9 For this reason, since the last decade, biochemical markers have been carefully investigated; among these, several have been related to the risk of death, myocardial infarction, or restenosis after PCI, but only C-reactive protein (CRP) has been consistently shown to significantly and independently confer an adverse prognosis in patients with coronary artery disease, including those undergoing PCI. 10 This is probably because of its relatively long half-life and chemical stability as well as the limited costs. 11 There are many studies to show the late complication; 12, 13 but there are few studies as well, which have provided consistent and compelling association of pre-procedural CRP with early complications. 14, 15 We conducted this study to correlate the level of CRP with in-hospital adverse outcome in patients undergoing PCI and to assess the procedural and clinical success of PCI in patients with elevated CRP level.
Our hypothesis was -high baseline C-Reactive Protein level independently predicts in-hospital adverse outcome after elective PCI.
Materials & Methods:
It was a n observational study conducted in Department of Cardiology,National Institute of Cardio-vascular Diseases, Dhaka, from January 2006 to December 2006. Patients who underwent percutaneous coronary intervention of native coronary arteries were considered for study. Patient with MI, multi vessel PTCA, total occlusion, previous PTCA or bypass surgery, left ventricular EF < 30%, recurrent inflammatory conditions known to increase CRP level or serum Creatinine >2.5 mg/dl were excluded from the study.
Considering inclusion and exclusion criteria consecutive 50 patients underwent percutaneous coronary intervention with CRP level <0.3 mg/dl and 50 angiographically matched patients with CRP level e"0.3mg/dl were studied.Patients with CRP level <0.3 mg/dl constituted Group-I and patients with CRP level e"0.3mg/dl Group-II. The study protocol was approved by the institutional review board. Informed consent was taken from each patient or from the legal guardian. All patients were informed about the study. Data were collected in an approved data collected form.
hypertension, diabetes, dyslipidaemia, smoking and family history of coronary artery disease (CAD). Echocardiographic variables specially included left ventricular ejection fraction (LVEF).
Pre-procedural angiographic variables including number of stenosed vessel (single /double /triple), degree of stenosis (0 to 100%) and type of lesion (ACC/AHA low-risk, intermediaterisk and high-risk lesions) were noted.
Observation during the procedure:
Procedural observations included observation of no reflow, slow reflow, side branch occlusion, residual stenosis, distal TIMI flow and immediate complications (e.g. abrupt occlusion, threatened occlusion, dissection, perforation, cardiogenic shock, significant arrhythmias, cardiac arrest, coronary artery spasm, emergency CABG and death).
Post-procedural evaluation:
All patients were observed meticulously during their hospital stay to see: Chest pain, Significant arrhythmia, Congestive cardiac failure, Cardiogenic shock, Emergency coronary artery bypass graft (CABG) surgery, CVA, Thromboembolism, Death.
Post-procedural follow-up began immediately after completion of the intervention itself, and was done hourly for the first 6 hours and then every morning and evening, or even more frequently if indicated. Subjective evidence of chest pain, breathlessness and pain in the limb through which vascular access was made were looked for. Pulse, blood pressure, chest, peripheral pulses and vascular access site were examined. Bed-side monitor parameters were noted and available medical records were scrutinized.
Twelve-lead ECGs were done: Immediately and twenty-four hours after the procedure, before discharge, and as necessary. CK-MB level in blood was measured six hours after the procedure and as necessary. All patients were followed-up throughout the period of index hospitalization till discharge or death.
Estimation of C-Reactive Protein:
We estimated High sensitive C-Reactive Protein (hs-CRP) by Immulite 2000 (DPC)/Vitros ECi System (J&J)/Abbott AxSym System Random Access Multibatch Immunoassay Analyzer.
Statistical analysis:
Data were collected in a pre-designed form. The data obtained, were expressed in frequency, percentage, mean ± standard deviation, as applicable. Comparison between groups was done by chi-square test, Student's t test, Fisher's exact test or others, as applicable.All data were analyzed by using computer-based SPSS (Statistical Program for Social Science) program, version 11.5.
Observations and Results:
A total of 100 consecutive patients were studied who underwent PTCA with stent. The main objectives of the study was to evaluate the predictive value of pre-procedural C-Reactive Protein on in-hospital (peri-procedural and predischarge) outcome after Percutaneous Coronary Intervention (PCI). Table I shows the age and sex distribution of the study subjects. In this study, the patients were grouped into two on the basis of hs-CRP level. The patients those who had hs-CRP level <0.3mg/dl considered as group I and those who had hs-CRP level e"0.3 mg/dl as group II. Then mean age of group I patients was 48.7±8.8 years and 47.9±7.6 years for group II patients. But the mean age difference was not statistically significant (p>0.05).
It was also found that among group I patients, 45(90.0%) were male and 5(10.0%) were female. Whereas among group II patients, 46(92.0%) were male and 4(8.0%) were female. No statistically significant sex difference was found between two groups of patients (p>0.05).
Table-II Distribution of risk factors of the study patients

Risk factors
Study subjects Total P value Group I Group II (n=100) (n=50) ( Table VI shows the inflation pressure and its duration for the intervention. It was found that no statistically significant mean difference was found between two groups of patients in terms of inflation pressure and its duration (p>0.05). Table X shows the in-hospital complications of the study subjects. It was found that the in-hospital complications was significantly high among the patients of group II (p<0.05). Among the patients of group I, (90.0%) of the patients had no complications, whereas among group II, (72.0%) had no complications. The most frequents complications among group I patients were recurrence of ischaemia (ST, T change) (4.0%) followed by hypotension/shock, arrhythmia, heart failure (2.0% each) , whereas among group II patients, the most frequent complications were recurrence of ischaemia (ST, T change) (16.0%) followed by arrhythmia, heart failure (8.0%), myocardial infarction (NSTMI+STEMI) (6.0%), hypotension/shock (4.0%) etc. Statistically significant (p<0.05) number of major adverse cardiac event occurred in group II 5(10.0%) compared to group I 0(0.0%). To assess the role of independent role of CRP for prediction of complications, multivariate analysis was done. Table XII shows multivariate logistic  regression analysis with high CRP (tertile II+III) as dependant variable and age, sex, HTN, smoking, diabetes, UA and MI as independent variable. It shows that elevated CRP having odd ratio of 3.45 -has got independent relationship with adverse outcome. It is also evident here that DM and UA and MI also have independent influence on PCI outcome.
Discussion:
In this prospective study, 100 patients were included out of 111 patients, who underwent percutaneous coronary intervention (PCI) in NICVD. Eleven of them were excluded because 3 of them underwent double vessel PCI, 2 had inflammatory disease, 3 had total occlusion and 2 had previous PTCA and another had serum creatinine >2.5 mg/dl. The study population was divided into two equal groups of 50 on the basis of pre-procedural CRP level. Patients having CRP level < 0.3 mg/dl were labeled as Group-I and e" 0.3 mg/dl were labeled as Group-II. Again on few important issues these patients were divided in three tertile depending on CRP level. To show the rate of complication is directly related with the level of CRP, the level of CRP was again divided in to three tertile. Tertile I-<0.3mg/dl, tertile II-0.3-1 mg/dl and tertile III-> 1 mg/dl.
In this study, the outcomes of PCI were observed in both the groups during and after the procedure as long as the patients remained in the hospital. The outcomes were determined in terms of angiographic, procedural and clinical success, as well as of associated complications during the aforementioned period.
The mean age of the study subjects was 48.2±8.1 years with a range from 31 to 70 years. The mean age of group-I patients was 48.7± 8.8 years and 47.9 ±7.6 years for group-II patients. But the mean age difference was not statistically significant (p>0.05) between two groups. The age structure was consistent with Ahmed et al 16 in a similar study showing angiographic severity in relation to CRP level. The majority (91%) of the study population was male and remaining 9% were female. But no statistical significant sex difference was found between two groups of patients (p>0.05). Similar pattern was noted by Rahman et al. 17 The body mass index for group-I was 25±2.3 and for group-II was 26.5±3.1. The difference was not significant.
Regarding the risk factors, smoking was most prevalent (68.0%) and (78.0%) in group-I and group-II respectively, followed by hypertension (46.0% vs 56.0%), diabetes mellitus (19.0% vs 26.0%), dyslilpidemia (22.0% vs 26.0%) and family history of IHD (36.0% vs 40.0%) in group-I and Group-II respectively, but no statistically significant difference was observed between two groups. Similar pattern of risk factors was found by Rahman et al. 17 & Ahmed et al. 16 However the studies carried out abroad by Chew et al. 15 Mean percent of ejection fraction (EF%) was 53.9±7.3 n group-I and mean percent of ejection fraction 52.2±7.4 in group-II. Although it was higher in group-I, no significance difference was marked. This observation is consistent with Chew et al. 15 In terms of number of vessels involved, no significant difference was observed between group-I and group-II regarding single vessel (48.0% vs 36.0%) and double vessel (42.0% vs 38.0%) involvement, but statistically significant difference was found regarding triple vessel disease (10.0% vs 26.0%) between the two groups. It indicates patients with high CRP level have higher number of triple vessel disease.
No statistically significant (p>0.05) difference was observed between group-I and group-II in term of type of lesion distribution, although type C lesion was obviously higher in group-II (16.0% vs 28.0%). In this study it was found that type B lesion was the commonest type of lesion in both the groups. This finding is consistent with Rahman et al. 17 In a study by Ahmed et al. 16 it was observed that significantly higher percentage of complex lesion was in patients with higher CRP level. In hospital complications were also significantly high in group-II (p<0.05) in comparison to group-I (10.0% vs 280%). Among the statistically significant complications were recurrence of ischemia (4.0% vs 16.0%) and myocardial infarction (0.0% vs 10.0%). The rate of complication is a bit higher than the findings by Chew et al. 15 but there is no other study to compare the in-hospital complication rate with this study.
Other complications like hypotension (2.0% vs 6.0%), arrhythmia (2.0% vs 8.0%) and heart failure (2.0% vs8.0%) were distinctly higher in group-II but this difference are not statistically significant. CVA and other thrombo-embolism, cardiovascular accidents, CABG and death were nil in both group-I and group-II. In the study by Chew et al. 15 death and myocardial infarction were observed in higher rate (10.0% vs 16.8%) than this study. For this higher rate no correlation could be made other than increase prevalent of hypertension (79.0% vs 51.0%). But Chew et al. did not label hypertension as an independent risk factor for complication.
Rahman et al. 17 showed in his study significantly higher morbidity and mortality in patients with Acute Coronary Syndrome with higher CRP level.
When the in-hospital complications were distributed according to increasing tertile of CRP, it showed a proportionate increase of complications ie, highest rate f complications were observed in highest tertile (Tertile III) of CRP. This pattern of complications is quite consistent with that of the study by Chew et al, 15 Winter et al 18 and Buffon et al. 14 21 lesion characteristic by Tana et al. 22 and White CJ et al. 23 and hemostatic variables by F.C. Schoebela 24 Evidence of intracoronary thrombus was found to be more consistent predictor of early adverse events, 21, 23 but its practical value is limited by its low prevalence in the baseline angiogram. 23 In clinical practice, unstable angina is the most important predictor of acute complication following PTCA; 25 however, our observation that CRP levels are even stronger predictor of early adverse events suggests that the degree of activation of inflammatory cells is a more important determinant of early outcome after PTCA than clinical instability.
Limitations of the study:
Although the result of this study supports the hypothesis, yet it has got some limitations.
-This was a prospective, observational study, not randomized.
-Sample size was small.
-Only in-hospital observations was done, long term follow up could increase the strength of this study.
-It was conducted in a single center.
Conclusion:
The study reveals that C -Reactive Protein level was a significant independent predictor of short term (procedural and pre-discharge) outcome following Percutaneous Coronary Intervention (PCI). Further clinical trials should be carried out to determine whether any measure like CRP reduction by statins , anti-inflammatory drugs or use of Gp IIb/IIIa receptor blocker could be helpful for patients with high pre-procedural level of CRP to reduce or prevent in hospital adverse outcome after PCI. Because of its relatively long half life and chemical stability as well as the limited costs and logistic hurdles faced by clinicians to measure it, CRP can be a very attractive and useful marker to accurately risk stratify patients before PCI.
